https://pipelinereview.com/sterna-biologicals-Reports-Phase-2a-Study-Data-Demonstrating-Efficacy-of-Its-GATA-3-Specific-DNAzyme-Formulation-SB012-in-Patients-with-Ulcerative-Colitis/